At a glance
- Originator Schering-Plough
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpes simplex virus infections
Most Recent Events
- 13 Jun 2001 No-Development-Reported for Herpes simplex virus infections in USA (Unknown route)
- 09 Dec 1997 A study has been added to the antimicrobial activities, pharmacodynamics and adverse events sections
- 24 Nov 1994 Preclinical development for Herpes simplex virus infections in USA (Unknown route)